Effects of corticotropin-releasing factor on brain serotonergic activity

Neuropsychopharmacology

Volumn 18, Issue 6, 1998, Pages 492-502

  Price, Michelle L ^a   Curtis, Andre L ^b   Kirby, Lynn G ^a   Valentino, Rita J ^b   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Corticotropin releasing factor; Dorsal raphe nucleus; In vivo microdialysis; Indoleamine; Serotonin; Striatum

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SEROTONINERGIC SYSTEM;

ANIMALS; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOTROPIN-RELEASING HORMONE; ELECTROPHYSIOLOGY; HYDROXYINDOLEACETIC ACID; INJECTIONS, INTRAVENTRICULAR; MALE; MICRODIALYSIS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0031898339     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00197-8     Document Type: Article

References (49)

1. Aghajanian GK, Foote WE, Sheard MH Lysergic acid diethyl amide. Sensitive neuronal units in the midbrain raphe Science. 161:1968;706-708.
2. Aghajanian GK, Foote WE, Sheard MH Action of psychotogenic drugs on single midbrain raphe neurons. J Pharmacol Exp Ther. 171:1970;178-187.
3. Akaoka H, Saunier C-F, Chergui K, Charlety P, Buda M, Chouvet G Combining in vivo volume-controlled pressure microejection with extracellular unit recording. J Neurosci Meth. 42:1992;119-128.
4. Azmitia EC, Segal M An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol. 179:1978;641-668.
5. Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psych. 144:1987;873-877.
6. Chalmers DT, Lovenberg TW, De Souza EB Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain. Comparison with CRF1 receptor mRNA expression J Neurosci. 15:1995;6340-6350.
7. Chaouloff F Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev. 18:1993;1-32.
8. Chou JM, Kirby LG, Lucki I Effect of forced swimming stress on extracellular levels of 5-HT in the dorsal raphe nucleus of the rat. Soc Neurosci Abstr. 21:1995;2058.
9. De Souza EB Corticotropin-releasing factor receptors in the rat central nervous system. Characterization and regional distribution J Neurosci. 7:1987;88-100.
10. De Souza EB, Van Loon GR Brain serotonin and catecholamine responses to repeated stress in rats. Brain Res. 367:1986;77-86.
11. Dunn AJ Stress-related changes in cerebral catecholamine and indoleamine metabolism. lack of effect of adrenalectomy and corticosterone J Neurochem. 51:1988;406-412.
12. Dunn AJ, Berridge CW Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav. 27:1987;685-691.
13. Dunn AJ, Berridge CW Physiological and behavioral responses to corticotropin-releasing factor administration. Is CRF a mediator of anxiety or stress Brain Res Rev. 15:1990;71-100.
14. Ehlers CL, Reed TK, Henricksen SJ Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology. 42:1986;467-474.
15. Geyer MA, Puerto A, Dawsey WJ, Knapp S, Bullard WP, Mandell AJ Histologic and enzymatic studies of the mesolimbic and neostriatal serotonergic pathways. Brian Res. 106:1976;257-270.
16. Gold PW, Chrousos GP, Kellner CH Overview; Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psych. 141:1984;619-627.
17. Kellar KJ, Brown PA, Madrid J, Bernstein M, Vernikos-Danellis J, Mehler WR Origins of serotonin innervation of forebrain structures. Exp Neurol. 56:1977;52-62.
18. Kirby LG, Allen AR, Lucki I Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 682:1995;189-196.
19. Kirby LG, Chou-Green JM, Davis K, Lucki I The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brian Res. 760:1997;218-230.
20. Kirby LG, Lucki I Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-HT and 5-HIAA in the rat. J Pharmacol Exp Ther. 282:1997;967-976.
21. Kreiss DS, Wieland S, Lucki I The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience. 52:1993;295-301.
22. Lavicky J, Dunn AJ Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem. 60:1993;602-612.
23. Liang KC, Melia KR, Miserendino MJD, Falls WA, Campeau S, Davis M Corticotropin-releasing factor. Long-lasting facilitation of the acoustic startle reflex J Neurosci. 12:1992;2303-2312.
24. Linthorst ACE, Flachskamm C, Hopkins SJ, Hoadley ME, Labeur MS, Holsboer F, Reul JMHM Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to the systemic inflammatory challenge. J Neurosci. 17:1997;4448-4460.
25. Linthorst ACE, Flachskamm C, Muller-Preuss P, Holsboer F, Reul JMHM Effect of bacterial endotoxin and interleukin-1b on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels. an in vivo microdialysis study J. Neurosci. 15:1995;2920-2934.
26. Menzaghi F, Rassnick S, Heinrichs S, Baldwin H, Pich EM, Weiss F, Koob GF The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal. Ann NY Acad Sci. 739:1994;176-184.
27. Morgan WW, Rudeen PK, Pfeil KA Effect of immobilization stress on serotonin content and turnover in regions of the rat brain. Life Sci. 17:1975;143-150.
28. Nemeroff C, Widerlov E, Bissette GT, Walleus H, Karlson I, Eklund K, Kilts C, Loosen P, Vale W Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
29. Nemeroff CB, Owens MJ, Bissette GT, Andorn AC, Stanley M Reduced corticotropin-releasing factor (CRF) binding sites in frontal cortex of suicide patients. Arch Gen Psych. 45:1988;577-579.
30. Orosco M, Nicolaidis S Insulin and glucose-induced changes in feeding and medial hypothalamic monoamines revealed by microdialysis in rats. Brian Res Bull. 33:1994;289-297.
31. Owens MJ, Nemeroff CB Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev. 43:1991;425-474.
32. Parsons LH, Koob GF, Weiss F Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther. 274:1995;1182-1191.
33. Plotsky PM Hypophysiotropic regulation of adenohypophyseal adrenocorticotropin secretion. Fed Proc. 344:1985;207-214.
34. Pol O, Campmany L, Gil M, Armario A Behavioral and neurochemical changes in response to acute stressors. Influence of previous chronic exposure to immobilization Pharmacol Biochem Behav. 42:1992;407-412.
35. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA. 91:1994;8777-8781.
36. Reul JMHM, Linthorst ACE Central administration of corticotropin-releasing hormone profoundly stimulates rat hippocampal serotonergic neurotransmission and behavioral activity. No effect of adrenalectomy Soc Neurosci Abstr. 23:1997;119.
37. Roy A, Pickar D, Linnoila M, Chrousos GP, Gold PW Cerebrospinal fluid corticotropin-releasing hormone in depression. Relationship to noradrenergic function Psych Res. 20:1987;229-237.
38. Rueter LE, Jacobs BL A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations. Brain Res. 739:1996;57-69.
39. Sakanaka M, Shibasaki T, Lederes K Corticotropin-releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidediaminobenzidene method. J Comp Neurol. 260:1987;256-298.
40. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res. 675:1995;89-97.
41. Singh VB, Hao-Phan T, Corley KC, Boadle-Biber MC Increase in cortical and midbrain tryptophan hydroxylase activity by intracerebroventricular administration of corticotropin-releasing factor. Block by adrenalectomy, by RU 38486 and by bilateral lesions to the central nucleus of the amygdala Neurochem Int. 20:1991;81-92.
42. Swanson LW Brain Maps Structure of the Rat Brain. 1992;Elsevier, Amsterdam.
43. Swanson LW, Sawchenko PE, Rivier J, Vale W Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in rat brain. An immuno-histochemical study Neuroendocrinology. 36:1983;165-186.
44. Tanaka M, Kohno Y, Nakagawa R, Nishikawa T, Tsuda A, Nagasaki N Immobilization stress increases serotonin turnover in the extended brain regions in the rat. Kurume Med J. 30:1983;35-43.
45. Vale W, Spiess J, Rivier C, Rivier J Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
46. Valentino RJ, Foote SL, Page ME The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann NY Acad Sci. 697:1993;173-188.
47. Van Loon GR, Shum A, Ho D Lack of effect of corticotropin-releasing factor on hypothalamic dopamine and serotonin synthesis turnover rates in rats. Peptides. 3:1982;799-803.
48. Vertes RP A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol. 313:1991;643-668.
49. Weiss F, Parsons LH, Schulteis G, Hyytia P, Lorang MT, Bloom FE, Koob GF Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci. 16:1996;3474-3485.